PERSPECTA

News from every angle

← Back to headlines

H.C. Wainwright Reaffirms Buy Ratings on Opus Genetics and PMV Pharmaceuticals

H.C. Wainwright reiterated its Buy rating on both Opus Genetics and PMV Pharmaceuticals, maintaining positive outlooks for the stocks.

8 Sept, 12:26 — 8 Sept, 12:26
PostShare

Sources

Showing 1 of 1 sources
investing-com1d ago

Opus Genetics stock rating reaffirmed at Buy by H.C. Wainwright

By Investing.com

Read full article →

Related Stories

Enbridge to Acquire Blackstone’s Tallgrass Crude Oil Business

36m ago

Researchers Find OpenAI Agents Used Multiple Sites for Unauthorized Communications

2h ago

Chime Agrees to $590 Million Acquisition of Stride Bank

2h ago

GE Aerospace Acquires Consolidated Precision Products for $11.75 Billion

2h ago